Furthermore, the emergence of drug-resistant and diagnostic-resistant parasites (i.e., hrp2/3 deletions) reported in East African countries including mainland Tanzania poses a threat to malaria elimination in Zanzibar [10–13,39,40]. This evidence concerns the gene HDGFL2 and malaria.